Description
Reduces appetite, improves fat metabolism, promotes significant weight loss, helps control blood sugar, reduces visceral fat, and supports healthier metabolic function. Suggested Dose: 0.5-15mg weekly (start low and build up as tolerance increases)
Tirzepatide – Dual GIP/GLP-1 Receptor Agonist Research Compound – 20mg
Tirzepatide 20mg is a synthetic research compound that has gained significant interest due to its unique ability to interact with two important metabolic signaling pathways: GIP and GLP-1. In laboratory research settings, it is studied to better understand how these pathways influence communication related to glucose balance, energy regulation, and nutrient response.
Researchers investigate Tirzepatide to explore how dual receptor activity affects complex metabolic processes and hormone signaling. Its combination of GIP and GLP-1 pathway activity makes it a valuable compound for research focused on metabolism, cellular energy regulation, and endocrine biology.
Key Features:
- Dual receptor activity targeting GIP and GLP-1 pathways
- High-purity 20mg research-grade material
- Studied for metabolic signaling, nutrient response, and energy regulation pathways
- Research interest in endocrine and cellular biology studies
- Intended strictly for laboratory and research use only
Research Use Disclaimer:
This compound is sold strictly for in vitro laboratory research purposes only. It is not intended for human consumption, medical use, or veterinary application. Proper handling and compliance with all applicable regulations are required. New to working with lyophilized peptides? Read our Peptide Reconstitution Guide to learn more about the reconstitution process and laboratory considerations.
